Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm

Abstract The present study entails the systematic development and validation of a stability-indicating RP-HPLC method for the analysis of sitagliptin and ertugliflozin in a fixed-dose combination. Analytical quality by design (AQbD) concepts were used to define critical method variables, employing P...

Full description

Bibliographic Details
Main Authors: Sunitha Gurrala, Shivaraj, Panikumar Durga Anumolu, Haripriya D, Subrahmanyam CVS
Format: Article
Language:English
Published: Universidade de São Paulo 2023-06-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502023000100379&tlng=en
_version_ 1797791434274766848
author Sunitha Gurrala
Shivaraj
Panikumar Durga Anumolu
Haripriya D
Subrahmanyam CVS
author_facet Sunitha Gurrala
Shivaraj
Panikumar Durga Anumolu
Haripriya D
Subrahmanyam CVS
author_sort Sunitha Gurrala
collection DOAJ
description Abstract The present study entails the systematic development and validation of a stability-indicating RP-HPLC method for the analysis of sitagliptin and ertugliflozin in a fixed-dose combination. Analytical quality by design (AQbD) concepts were used to define critical method variables, employing Pareto risk assessment and a Placket-Burman screening design, preceded by a Box-Behnken design with response surface analysis to optimise critical method parameters such as % acetonitrile (X1), buffer pH (X2) and column oven temperature (X3). Multiple response optimisation (Derringer’s desirability) of variables was accomplished by studying critical analytical attributes, such as resolution, retention time and theoretical plates. The title analytes were separated effectively on a PRONTOSIL C18 column at 37 °C using a mobile phase of acetonitrile:acetate buffer, pH 4.4 (36:64 percent v/v), pumped at a flow rate of 1 mL/min, and UV detection at 225 nm. Linearity was observed over a concentration range of 25-150 µg/mL and 3.75-22.5 µg/mL at retention times of 2.82 and 3.92 min for sitagliptin and ertugliflozin, respectively. The method obeyed all validation parameters of the ICH Q2(R1) guidelines. The proposed robust method allows the study of the selected drugs in pharmaceutical dosage forms as well as in drug stability studies under various stress conditions.
first_indexed 2024-03-13T02:19:46Z
format Article
id doaj.art-326e26a1435041f7ae217dfb51d70c4a
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-03-13T02:19:46Z
publishDate 2023-06-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-326e26a1435041f7ae217dfb51d70c4a2023-06-30T10:47:51ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902023-06-015910.1590/s2175-97902023e21328Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigmSunitha GurralaShivaraj https://orcid.org/0000-0001-6251-2763Panikumar Durga AnumoluHaripriya DSubrahmanyam CVSAbstract The present study entails the systematic development and validation of a stability-indicating RP-HPLC method for the analysis of sitagliptin and ertugliflozin in a fixed-dose combination. Analytical quality by design (AQbD) concepts were used to define critical method variables, employing Pareto risk assessment and a Placket-Burman screening design, preceded by a Box-Behnken design with response surface analysis to optimise critical method parameters such as % acetonitrile (X1), buffer pH (X2) and column oven temperature (X3). Multiple response optimisation (Derringer’s desirability) of variables was accomplished by studying critical analytical attributes, such as resolution, retention time and theoretical plates. The title analytes were separated effectively on a PRONTOSIL C18 column at 37 °C using a mobile phase of acetonitrile:acetate buffer, pH 4.4 (36:64 percent v/v), pumped at a flow rate of 1 mL/min, and UV detection at 225 nm. Linearity was observed over a concentration range of 25-150 µg/mL and 3.75-22.5 µg/mL at retention times of 2.82 and 3.92 min for sitagliptin and ertugliflozin, respectively. The method obeyed all validation parameters of the ICH Q2(R1) guidelines. The proposed robust method allows the study of the selected drugs in pharmaceutical dosage forms as well as in drug stability studies under various stress conditions.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502023000100379&tlng=enAQbDHPLCSitagliptinErtugliflozinStability-indicating
spellingShingle Sunitha Gurrala
Shivaraj
Panikumar Durga Anumolu
Haripriya D
Subrahmanyam CVS
Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
Brazilian Journal of Pharmaceutical Sciences
AQbD
HPLC
Sitagliptin
Ertugliflozin
Stability-indicating
title Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
title_full Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
title_fullStr Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
title_full_unstemmed Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
title_short Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
title_sort chromatographic study of sitagliptin and ertugliflozin under quality by design paradigm
topic AQbD
HPLC
Sitagliptin
Ertugliflozin
Stability-indicating
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502023000100379&tlng=en
work_keys_str_mv AT sunithagurrala chromatographicstudyofsitagliptinandertugliflozinunderqualitybydesignparadigm
AT shivaraj chromatographicstudyofsitagliptinandertugliflozinunderqualitybydesignparadigm
AT panikumardurgaanumolu chromatographicstudyofsitagliptinandertugliflozinunderqualitybydesignparadigm
AT haripriyad chromatographicstudyofsitagliptinandertugliflozinunderqualitybydesignparadigm
AT subrahmanyamcvs chromatographicstudyofsitagliptinandertugliflozinunderqualitybydesignparadigm